p19Arf inhibits the invasion of hepatocellular carcinoma cells by binding to C-terminal binding protein.
about
An integrated computational/experimental model of lymphoma growthC-terminal binding protein-2 promotes cell proliferation and migration in breast cancer via suppression of p16INK4A.Transcription factor co-repressors in cancer biology: roles and targetingIntegrated analysis of the heterogeneous microarray data.Bidirectional autoregulatory mechanism of metastasis-associated protein 1-alternative reading frame pathway in oncogenesis.CDK5RAP3 is a novel repressor of p14ARF in hepatocellular carcinoma cells.Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance.Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression.C-Terminal Binding Protein: A Molecular Link between Metabolic Imbalance and Epigenetic Regulation in Breast Cancer.Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma.The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis.The transcriptional corepressor CtBP: a foe of multiple tumor suppressors.Deregulation of FoxM1b leads to tumour metastasis.CtBP2 overexpression is associated with tumorigenesis and poor clinical outcome of prostate cancerInsulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1.Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma.Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer.p16 Stimulates CDC42-dependent migration of hepatocellular carcinoma cellsDifferential roles of insulin-like growth factor receptor- and insulin receptor-mediated signaling in the phenotypes of hepatocellular carcinoma cells.Differentiated epithelial- and mesenchymal-like phenotypes in subcutaneous mouse xenografts using diffusion weighted-magnetic resonance imaging.Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61.Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cellsThe Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target.Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells.Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP).Pontin, a new mutant p53-binding protein, promotes gain-of-function of mutant p53.CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16INK4A.High expression and prognostic role of CAP1 and CtBP2 in breast carcinoma: associated with E-cadherin and cell proliferation.CtBPs promote mitotic fidelity through their activities in the cell nucleus.An ARF/CtBP2 complex regulates BH3-only gene expression and p53-independent apoptosisp19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia.CtBP2 Promotes Human Cancer Cell Migration by Transcriptional Activation of Tiam1.Therapeutic targeting of C-terminal binding protein in human cancer.Transcriptional corepressors in cancer: emerging targets for therapeutic intervention.CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma.
P2860
Q28489081-2BB89A05-66C3-444A-A60F-CE4F83BE0108Q33688570-F2169806-B952-4CCE-8155-AF8440EE119BQ33762000-01534373-1843-4DAB-A925-C0E0C6E2E44EQ34046445-A2C33192-69B3-4B15-8AE6-872DBE640039Q34183797-0B1E5056-4A67-4418-97DB-6E618D27B5B5Q34364651-0633A487-3149-4905-8ED6-D0AB96A753ADQ34370226-75C2F6B6-DFC5-4A07-AA7A-44DF7987AF37Q34399237-9FF82113-79C5-447D-BFB3-84DF69ED9A4DQ34769289-3514F565-91D3-4401-9588-70826363964EQ34786517-3EB8EDD8-CBC1-4884-8B00-CAA0C0C26758Q35118952-EE4D3CDB-E73E-4C1A-8423-B3970FCD2404Q35200291-4F1A858F-C5B9-4C49-9A7F-FD860C8612A9Q36108360-E302B06F-FCBE-4C84-BE3D-6979383B4AE9Q36419023-6EF10B41-5649-4E4B-8485-B1A99EB374C3Q36561601-A93B1944-AA76-4723-80FA-E88391B2CBA3Q36857482-0A007528-8C5F-4ECC-9902-806403802800Q36972125-686B39A3-7966-4DB4-92AF-142BF5F7F8C0Q37042920-FF33ACBA-C3CC-4C18-A657-269BF4736076Q37327775-9194E687-E2E9-402A-BFAB-D5B07515FB94Q37375404-D80F3547-1399-426E-A420-434568BD832DQ37447362-C316075C-63C6-48D6-80DA-F60EA6A54D9AQ37493295-4C534904-F521-4222-A665-9CE0F3D9D48FQ38675402-C4FE902B-05DF-4881-B31D-C45C935A35CCQ38748269-02167E59-F1EC-47BA-9A73-1DB7E7B555B6Q38772484-3D02309B-DC01-4A69-8C42-2B86D27C6211Q38889305-AFD2A85C-8953-4AD2-9B18-E267DEB5B9E7Q39223192-58FAA042-F135-440F-80F3-6032CA4CF6F1Q39251443-B6B0B327-99D1-4186-9E00-E9C67F5B7D62Q39634740-CAF102FA-AC7C-49D7-A2BC-6194AD272543Q39792504-6DE89D1E-D83C-45A5-8E21-D475AECFE0BBQ40071869-5CC644E4-3C4C-4848-97A3-BF15C3294036Q41861546-FCECFDC2-DE3D-4F55-AA96-3DC4FE1FB1CAQ42119721-074BF659-5F0D-4781-A1ED-66205B5D7E81Q44917007-A7174BD3-38F9-4837-AC56-6C2B82D36B47Q53272755-F3C745D6-F229-44DA-BA57-C18F7605DE63
P2860
p19Arf inhibits the invasion of hepatocellular carcinoma cells by binding to C-terminal binding protein.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
p19Arf inhibits the invasion o ...... to C-terminal binding protein.
@en
type
label
p19Arf inhibits the invasion o ...... to C-terminal binding protein.
@en
prefLabel
p19Arf inhibits the invasion o ...... to C-terminal binding protein.
@en
P2093
P2860
P1433
P1476
p19Arf inhibits the invasion o ...... to C-terminal binding protein.
@en
P2093
Brian C Lewis
Kyle Draheim
Seema Paliwal
Steven R Grossman
Ya-Wen Chen
P2860
P304
P356
10.1158/0008-5472.CAN-07-1960
P407
P577
2008-01-01T00:00:00Z